Contrast-induced nephropathy.
暂无分享,去创建一个
[1] M. Rudnick,et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. , 2000, Kidney international.
[2] R. Gupta,et al. The renal patient with coronary artery disease: current concepts and dilemmas. , 2004, Journal of the American College of Cardiology.
[3] N. Chalmers,et al. Comparison of iodixanol and iohexol in renal impairment. , 1999, The British journal of radiology.
[4] G. Stone,et al. A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention , 2003 .
[5] P. Aspelin,et al. Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach , 2006, Circulation.
[6] M. Leon,et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. , 1999, The American journal of cardiology.
[7] G. Stone,et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.
[8] F. Veglia,et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[9] M. Tonelli,et al. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. , 2004, Kidney international.
[10] W. O’Neill,et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.
[11] A. Wragg,et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. , 2003, Journal of the American College of Cardiology.
[13] M. Rich,et al. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. , 1990, Archives of internal medicine.
[14] Sven-Göran Fransson,et al. Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.
[15] S. Hou,et al. Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] B. Krämer,et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. , 2004, Journal of the American Society of Nephrology : JASN.
[17] F. Markowetz,et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis , 2003, The Lancet.
[18] K. Shojania,et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. , 2004, The American journal of medicine.
[19] D. Malenka,et al. N‐acetylcysteine prophylaxis significantly reduces the risk of radiocontrast‐induced nephropathy: Comprehensive meta‐analysis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.
[21] Allen J. Taylor,et al. Clinical InvestigationsCardiologyPREPARED: PREParation for Angiography in REnal Dysfunction: A Randomized Trial of Inpatient vs Outpatient Hydration Protocols for Cardiac Catheterization in Mild-to-Moderate Renal Dysfunction , 1998 .
[22] L. Gruberg. Clinical features and prognostic implications of contrast-induced nephropathy , 2005 .
[23] G. Dangas,et al. Acute renal failure requiring dialysis after percutaneous coronary interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] J. Ix,et al. N-acetylcysteine for the prevention of contrast-induced nephropathy , 2005, Journal of General Internal Medicine.
[25] W Zidek,et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.
[26] Douglas Losordo,et al. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). , 2002, The American journal of cardiology.
[27] P. Persson,et al. Contrast medium-induced nephropathy: the pathophysiology. , 2006, Kidney international. Supplement.
[28] G. Marenzi,et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.
[29] K. Harjai,et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.
[30] F. Veglia,et al. N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty , 2006 .
[31] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[32] R. Erbel,et al. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. , 2006, Clinical nephrology.
[33] S. Sdringola,et al. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[34] J. Bover,et al. Does hydration prevent radiocontrast-induced acute renal failure? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] Kirk N. Garratt,et al. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.
[36] F. Veglia,et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. , 2006, The American journal of medicine.
[37] F. Veglia,et al. Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.
[38] Gilles Soulez,et al. Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Computed Tomography: A Double-Blind Comparison of Iodixanol and Iopamidol , 2006, Investigative radiology.
[39] C. Briguori,et al. Contrast-induced nephropathy: pharmacological prophylaxis. , 2006, Kidney international. Supplement.
[40] E. Kline-Rogers,et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. , 2005, The American journal of medicine.
[41] W. O’Neill,et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study , 1999 .
[42] E. Bates,et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[43] A. Szabo,et al. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. , 2009, The American journal of medicine.
[44] A. Agrawal,et al. A Randomized Prospective Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity , 2003, Nephron Clinical Practice.
[45] E. Halpern,et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.
[46] D. Cokkinos,et al. Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study , 2006, European Journal of Clinical Pharmacology.
[47] H. Miller,et al. Effects of an Acute Dose of L-Arginine during Coronary Angiography in Patients with Chronic Renal Failure , 2003, American Journal of Nephrology.
[48] P. Nilsson-ehle,et al. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. , 1995, Nephron.
[49] G. Sterner,et al. Does Post-angiographic Hemodialysis Reduce the Risk of Contrast-medium Nephropathy? , 2000, Scandinavian journal of urology and nephrology.
[50] R. Luther,et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. , 1999, Critical care medicine.
[51] T. Lehnert,et al. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[52] G. Deray,et al. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. , 2006, Kidney international. Supplement.
[53] R. Gupta,et al. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. , 1999, Indian heart journal.
[54] J. Yee,et al. The potential role of statins in contrast nephropathy. , 2004, Clinical nephrology.
[55] A. Serra,et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.
[56] G. Marenzi,et al. Recent advances in the prevention of radiocontrast-induced nephropathy , 2004, Current opinion in critical care.
[57] B. Jaber,et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] J. Kaski,et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.
[59] C. Poole,et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. , 2004, Journal of the American Society of Nephrology : JASN.
[60] Young‐Bae Park,et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.
[61] J. D'Elia,et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.
[62] M. Gotsman,et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. , 1999, Journal of the American College of Cardiology.
[63] S. Bagshaw,et al. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis , 2004, BMC medicine.
[64] Chi‐Hang Lee,et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. , 2003, JAMA.
[65] M. Shapiro,et al. Role of N‐acetylcysteine in prevention of contrast‐induced nephropathy after cardiovascular procedures: A meta‐analysis , 2004, Clinical cardiology.
[66] R. Bellomo,et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients* , 2007, Critical care medicine.
[67] R. Katzberg,et al. Contrast-induced nephrotoxicity: clinical landscape. , 2006, Kidney international. Supplement.
[68] A. Wenning,et al. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[69] B. Barrett,et al. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.
[70] R. Katzberg,et al. Risk of iodinated contrast material--induced nephropathy with intravenous administration. , 2007, Radiology.
[71] K. Shyu,et al. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. , 2002, Journal of the American College of Cardiology.
[72] T. L. Pinto,et al. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients. , 2006, The American journal of cardiology.
[73] D. Greenwood,et al. Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention , 2004, Circulation.
[74] Aslihan Büyüköztürk Karul,et al. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures , 2006, Heart.
[75] P. Persson,et al. Pathophysiology of contrast medium-induced nephropathy. , 2005, Kidney international.
[76] G. Stone,et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. , 2003, JAMA.
[77] D. Roe,et al. Predicting angiography-induced acute renal function impairment: clinical risk model. , 1983, AJR. American journal of roentgenology.
[78] V. Guru,et al. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. , 2004, Clinical nephrology.
[79] P. Parfrey,et al. Preventing Nephropathy Induced by Contrast Medium , 2006 .
[81] C. Viscoli,et al. The effect of acute renal failure on mortality. A cohort analysis. , 1996, JAMA.
[82] A. Colombo,et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. , 2004, European heart journal.
[83] C. McCulloch,et al. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[84] Jiaquan Zhu,et al. N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model. , 2007, The Journal of thoracic and cardiovascular surgery.
[85] B. Villari,et al. Acetylcysteine and contrast agent-associated nephrotoxicity. , 2002, Journal of the American College of Cardiology.